Skip to main content
Premium Trial:

Request an Annual Quote

IBC s Assays & Cellular Targets Conference

Premium

IBC announced last week the keynote speakers for its Assays & Cellular Targets conference, to be held October 18-21 at the Sheraton San Diego Hotel & Marina in San Diego. Speakers include:

Jerrold Olefsky, MD, Professor of Medicine, Endocrinology and Metabolism, University of California, San Diego

Bart Sefton, PhD, Professor, The Salk Institute

Lansing Taylor, PhD, Director, Cellomics

Ralph Garippa, PhD, Research Leader, Cell-based High Throughput Screening & Automation, Hoffmann-La Roche

Krzysztof Palczewski, PhD, Departments of Ophthalmology, Pharmacology, and Chemistry, University of Washington

Graeme Milligan, PhD, Professor of Molecular Pharmacology & Biochemistry, University of Glasgow

Reinhold Penner, MD PhD, Professor of Cell and Molecular Signaling, Center for Biomedical Research at The Queen’s Medical Center and John A. Burns School of Medicine, University of Hawaii

Bertil Hille, PhD, Professor of Physiology and Biophysics, University of Washington School of Medicine

Further information about the conference can be found at the official website, http://www.lifesciencesinfo.com/ACT.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.